メラノーマの生物学と新しい標的治療法

Vanessa Gray-Schopfer¹, Claudia Wellbrock, Richard Marais

¹The Institute of Cancer Research, Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, UK.

Nature

|February 23, 2007

まとめ

染色体細胞による皮膚がんであるメラノーマは,世界中で増加しています. 新しい細胞シグナル伝達に関する洞察は,治療が難しいこの病気の標的治療を推進しています.

科学分野:

腫瘍学腫瘍学
皮膚科皮膚科について
細胞生物学細胞生物学

背景:

メラノーマは,皮膚の特殊な色素細胞であるメラノサイトから発生します.
メラノーマの発生率は世界的に上昇しており,西欧諸国では過去20年間で倍増しています.
初期段階のメラノーマは手術で治るが,転移性メラノーマは治療に耐性がある.

研究の目的:

メラノーマの生物学的理解における最近の進歩を強調するために.
新しい発見に基づいたターゲティング医薬品と新種の治療法の開発について議論する.
先進的なメラノーマの治療の課題に取り組むために.

主な方法:

メラノーマ細胞の信号伝達経路における最近の発見のレビュー.
新興の標的薬物開発戦略の分析.
メラノーマに対する新しい治療アプローチの探索.

主要な成果:

メラノーマを誘発する分子機構の理解を深めた.
メラノーマの進行に不可欠な重要な細胞信号伝達経路の特定.
特定のメラノーマの脆弱性を標的とした新しい治療戦略の開発.

結論:

細胞シグナル伝達の研究の進歩は,メラノーマとの闘いにおいて極めて重要です.
ターゲティングセラピーは,進行メラノーマの治療に新たな希望をもたらします.
メラノーマの生物学に関する継続的な研究は,患者のアウトカムを改善するために不可欠です.

さらに関連する動画

07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

関連する概念動画

02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

02:57

Targeted Cancer Therapies

01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

関連する実験動画